Together, our data define the tumor-promoting role of CORO6 in ccRCC progression and provide a compelling rationale to develop CORO6-targeted therapies for improved treatment of ccRCC patients. The gene discussed is CORO6; the disease is nonpapillary renal cell carcinoma.